BRIEF-Lepu Biopharma Enters Licensing Deal With Excalipoint
Reuters
Aug 01
BRIEF-Lepu Biopharma Enters Licensing Deal With Excalipoint
Aug 1 (Reuters) - Lepu Biopharma Co Ltd 2157.HK:
ENTERS LICENSING DEAL WITH EXCALIPOINT
TO RECEIVE UP TO $847.5 MILLION IN MILESTONES UNDER DEAL
TO RECEIVE UPFRONT $10 MILLION CASH AND 10% EQUITY, OTHERS
Further company coverage: 2157.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.